Lecture 6: HF Flashcards

1
Q

pts diagnosed w HF have a ____________ _____________ mortality rate after their 1st hospital admission

A

50% 5-year

one in every 2 pts diagnosed will die at 5 yrs, this increases w each hospitalization, and profoundly after the 3rd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

common misconceptions around HF

A

It is a chronic condition, can come on suddenly
Long term condition
Your heart does not stop beating - it just beats ineffectively
This is NOT normal for aging, comes from damage to the heart muscle
More exacerbations the more compromises the patient will have

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is HF

A
  • characterized by inability of myocardium to pump enough blood to meet body needs
  • abnormal clinical syndrome involving impaired cardiac pumping or filling, or both
  • response to cardiac dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the most common cause of HF

A

Most common cause of heart failure: HTN (because heart is pumping against pressure, and if it can’t pump effectively it decreases C/O)
Maintain our hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what can high cholesterol lead to

A

High cholesterol -> coronary artery disease -> heart attack and stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what can hypertrophy of the heart cause

A

Hypertrophy heart -> you wont have the same filling as you would if your heart could relax causing decreased C/O.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why is increased HR bad

A

Increased HR - decreasing filling time - don’t get perfusion from arteries to heart - so overall less effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is valvular disease

A

Valvular disease -> when valves don’t open and shut properly. If your valves aren’t shutting properly, we won’t have that closed system and will have leakage. If we have stenosis - this will be pushing against higher pressure, so takes more energy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

R sided HF

A

R sides HF - having trouble pulmonary system (PE, pulmonary HTN - will increase pressure in this system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

L sided HF

A

L side - having trouble pumping to systemic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

top 3 most common HF causes

A
  • CAD -> MI
  • hypertension
  • valvular disease -> rheumatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

most common causes of HF overall (a lot)

A
  • CAD, MI
  • HTN
  • valvular disease
  • CHD
  • pulm HTN (r sided), PE
  • infiltrative disorders
  • pericardial disease
  • inflammatory (myocarditis)
  • cardiomyopathy
  • dysrhythmias
  • meds non-compliance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

review norm circulation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are 3 major sys that are recruited when myocardial injury occurs

A
  1. SNS
  2. RAAS
  3. Natriuretic peptide sys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

explain how the 3 major sys that are recruited when myocardial injury occurs (i am sorry this is so long fix this slide)

A

Myocardial dysfunction
- Decreased CO, systemic bp, and perfusion to kidneys
So this stim SNS sys - what can we do to increase output?
Can increase bp, and HR to help perfusion.
Vasoconstriction - increased BP and HR
Good ideas except, heart is not pumping enough out bc its failing, so makes it difficult to do its job. So this isn’t very helpful. Lessens our perfusion, increase stuff on the heart. Not great if someone has HF.
Our HF pts are on beta blockers bc it interferes w SNS.
Will also activate our RAAS sys -> causes vasoconstriction - increasing bp, stim release of aldosterone, also increase pressure, further cause vasoconstriction, increase pertrophy?, overtime these are not helpful not good longterm. -> so to stop our RAAS sys = we use ACE inhibitors + ARBs if they cant tolerate ACE.
Natriuretic peptide sys - in our atria and ventricles, increased stretch our heart releases these peptides, increased stretch = increased volume, which we know in HF we are not pumping out well, if RAAS sys is instigated and retaining fluid - this puts up our volume. Our pituitary gland - antidiuretic hormone - works on distal tubules to increase volume - and then we have stretch - our heart releases our naturetic peptides, and they do a few things. They interfere w RAAS sys, cause vasodilation, increase excretion of Na and H2o, we like this sys so we do things to keep making this system work.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how does SNS elevation try to compensate for HF

A
  • increases HR and contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how does neural-hormonal response try to compensate for HF

A
  • increase in Na and H2O retention (RAAS)
  • posterior pituitary gland secretes ADH
  • production of endothelin - potent vasoconstrictor
  • proinflammatory cytokines are released by heart - causing hypertrophy, contractile dysfunction, and cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does the frank starling mechanism try to compensate for HF

A
  • dilation of ventricle
  • increased pressures result in increased volume at end of diastole
  • increased stretch initially adaptive - eventual overstretch results in ineffective contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how does ventricular hypertrophy try to compensate for HF

A
  • increase in muscle mass and cardiac wall thickness in response to overwork and strain
  • develops overtime, generally following persistent or chronic dilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what do HF hearts look like + why is hypertrophy not great

A

HF can have big stretchy hearts.
Initially more heart muscle is good, but overall not sustainable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what does the natriuretic peptide system impact + what are the 2 natriuretic peptides

A
  • impacts salt and water handling, pressure regulation, and may influence myocardial structure and function
  1. BNP (brain natriuretic peptide)
  2. ANP (atrial natriuretic peptide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

BNP (brain natriuretic peptide)

A

a natriuretic hormone primarily released from the heart - particularly the ventricles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ANP (atrial natriuretic peptide)

A

a hormone released by the myocardial cells in the atria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what similarities does the 2 natriuretic peptides have

A
  • both are released in response to increased wall stress and volume expansion
  • both have diuretic, natriuretic, and hypotensive effects
  • both inhibit RAAS and impair systemic and renal sympathetic activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

in comparison to other compensatory mechanisms - which one is actually a good thing

A

The natriuretic peptide system is a good thing - the others not so much so we try and help the peptide system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what 3 sys kick in to regular the issue w HF

A

SNS + RAAS + NP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

over time the compensatory mechanisms become maladaptive… why is this (4)

A
  • elevation of diastolic pressures transmitted to atrial/pulmonary/systemic venous circulations promotes congestion and edema
  • increase in LV afterload (vasoconstriction) can both directly depress cardiac function and enhance the rate of deterioration of myocardial function
  • increases contractility, HR, LV afterload can worsen or provoke coronary ischemia
  • catecholamines, angiotensin 2, aldosterone promote the loss of myocytes through apoptosis, and cause myocardial hypertrophy and fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

describe acute HF

A

often related to a significant event like a MI. can progress over days or hours.

sudden onset, w no compensatory mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

describe chronic HF + s/s

A

CAD, HTN, valvular disease. They can also have acute on chronic event

  • ongoing process mo to yrs
  • progressive worsening of ventricular function
  • chronic neuro-hormonal activation that results in ventricular remodelling
  • fatigue, dyspnea, tachycardia, edema, nocturia, depression chest pain, wt changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

describe L sided HF

A
  • left ventricular dysfunction
  • disturbance of contractile function of L ventricle, resulting in low c/o state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

describe R sided HF

A
  • ineffective R ventricular contractile function
  • backwards flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what kind of HF do most ppl have…

A

Where does blood come from to L side of heart - backing up into lungs - so if we increase pressure bc L side of heart is failure, puts pressure on the R side. Most ppl have this bc L ventricle is compromised.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

systolic HF

A
  • abnormality of heart muscle that markedly decreases contractility during systole (ejection) and lessens the quantity of blood that can be pumped out of the heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

diastolic HF

A
  • describes abnormality of heart muscle that makes it unable to relax, stretch, or fill during diastole, EF can be normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

if your heart is having a pumping problem…

A

Pumping problem - systolic problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

if your heart is having a filling problem…

A

Or filling problem - heart is resting diastolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

describe ejection fraction

A

calculated doing a ultrasound and look at the V in the L ventricle, and then they calculate how much blood is pumped out. If L ventricle held 100 mLs pumps out 50, your % would be 50%.
CO is V that is being pumped out.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

if you have a problem w filling… and you only have 50 mLs ad you pump out 25mLs what % is this…

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

diastolic problem

A

their ejection fraction is rly good, but their volume being pumped out is bad.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

describe heart failure reduced ejection fraction (HFrEF)

A
  • formally called systolic dysfunction - inability to pump
  • LVEF <40%
  • aggressively treated w medical therapy and cause for etiology determined ASAP

Ejection fraction less than 40%, rly bad at pumping the volume out. Treat w beta blockers, ACE inhibitors.

41
Q

describe heart failure preserved ejection fraction (HFpEF)

A
  • formally called diastolic dysfunction - inability to relax
  • LVEF >50%
  • treatment of symptoms

Heart doesn’t fill very well - decreased CO. treat sympt.

42
Q

describe heart failure midrange ejection fraction (HFmEF)

A
  • “new” classification of pts
  • LVEF 40-49%
  • treatment pathway still under review, may be individualized

Mix of both the above for treatment. bit of a pump and fill problem. Decreased CO.

43
Q

what are 5 complications of HF

A
  • pleural effusions
  • dysrhythmias
  • L ventricular thrombus
  • hepatomegaly
  • renal failure
44
Q

what is a pleural effusion

A

backing fluid into our lungs increases pressure. Movement of fluid outside capillaries. Build of of pressure and fluid.

45
Q

what causes dysrhythmias

A

enlarged chambers, electrolyte imbalances, etc.

46
Q

what is L ventricular thrombus

A

blood stagnant in atria, pt at risk for clot. Ventricle not pumping well can also cause clotting. Want to treat this so a clot is not pumped out.

47
Q

what is hepatomegaly

A

increase in fluid in liver sys

48
Q

what is renal failure

A

ex of prerenal because we are not perfusing them

49
Q

R sided HF s/s

A
  • fatigue, weakness
  • hypotension: reflects severe disease
  • fluid overload
  • wt gain
  • anorexia
  • peripheral edema, +/- JVP
  • decreased SaO2
  • murmurs
  • ascites/anasarca (massive, generalized body edema)
  • hepatomegaly
  • R heaves
  • renal impairment
  • tachypnea
  • tachycardia
50
Q

L sided HF s/s

A
  • fatigue, weakness
  • HTN
  • hypotension - reflects severe disease
  • fluid overload
  • wt gain
  • pulmonary edema (crackles)
  • decreased SaO2
  • extra heart sounds (S3 and S4)
  • peripheral edema
  • L heaves
  • renal impairment
  • tachypnea
  • tachycardia
  • nocturia
  • dyspnea
  • orthopnea
51
Q

w R sided HF what do u get

A
  • congestion of peripheral tissues
  • dependent edema and ascites
  • GI tract congestion
  • liver congestion
52
Q

w L sided HF what do you get

A
  1. decreased c/o
  2. pulmonary congestion
    - impaired gas exchange
    cyanosis and signs of hypoxia
    - pulmonary edema
    cough with frothy sputum, orthopnea, paroxysmal nocturnal dyspnea
53
Q

SOBOE (on exertion) is a early symptom of HF from…

A

pulmonary congestion

54
Q

described what would be diff on assessment w HF from normal

A
  • severely decompensated HF including hypotension, worsening renal function, or altered mentation
  • dyspnea at rest
  • worsened congestion, even if w/o dyspnea at rest
  • s.s of pulmonary or systemic congestion even in absence of wt gain
  • major electrolyte disturbance
  • associated comorbid conditions such as pneumonia, pulmonary embolus, DKA, ACS, or stroke symptoms
  • repeated implantable cardioverter defibril firings
  • previously undiagnosed HF w s/s of systemic or pulm congestion
  • hemodynamically significant arrhythmia including new onset of atrial fibrillation w rapid ventricular response
55
Q

early abnorm heart sound

56
Q

late abnorm heart sound

57
Q

what are S3 S4

A

3rd and 4th heart sounds are resistance to filling
S3 and s4 can’t fill properly
At risk for HF

58
Q

describe murmurs

A

not going to get tested on thank god but murmurs are turbulent blood flow + usually indicative of abnormal blood flow, or something is impeding it

59
Q

grade 1 class for ejection fraction

A

normal
>50%

Rarely eject greater than 80%
Greater than 50% is chill (50-80)

60
Q

grade 2 class for ejection fraction

A

mild
41-49%

41-49 is compromised (mixed HF - combo of pumping and filling)

61
Q

grade 3 class for ejection fraction

A

moderate
30-41%
Less than 40 - Pt w reduced ejection fraction

62
Q

grade 4 class for ejection fraction

A

severe
<30%

Less then 30% this is quite severe - “cardiac cripples”

63
Q

what lab work do we do for HF

A
  • BNP (brain natriuretic peptide)
  • renal function
  • glucose
  • CBC
  • liver function/hepatic congestion
  • thyroid function
  • electrolytes - Na+,K+
  • troponin, CK
  • blood gases
64
Q

what are u at risk for slow rhythm if u have

A

hypothyroidism

65
Q

tell me about BNP lab work readings

A
  • can be elevated in pts w renal failure (products cleared by kidneys)
  • also elevated in CAD, valvular heart disease, pulmonary hypertension, sepsis
66
Q

diagnostics for HF

A
  • ECG
  • Chest radiograph
  • Echo
  • Exercise Testing
  • Stress Test
  • MRI - cardiac
  • Cardiac Catheterization
67
Q

in HF what do we look at with ECG’s

A

for evidence of ischemia, infarction, arrhythmia (ex: afib)

68
Q

what does chest radiograph in HF look at

A
  • assess for signs of pulm edema, cardiomegaly, alternative diagnoses (ex: pneumonia)
  • norm radiograph does not rule out HF
69
Q

what does an Echo look at for HF

A
  • ejection fraction
  • if cardiac or valvular function is not known
  • f/u to compare to previous
70
Q

what is NYHA class

A

new york heart association classification

71
Q

NYHA Class 1

A
  • no symptoms
  • can perform ordinary activities w/o any limitations
72
Q

NYHA Class 2

A
  • mild symptoms
  • occasional swelling
  • somewhat limited in ability to exercise or do other strenuous activities
  • no symptoms at rest
73
Q

NYHA Class 3

A
  • noticeable limitations in ability to exercise or participate in mildly strenuous activities
  • comfortable only at rest
74
Q

NYHA Class 4

A
  • unable to do any physical activity without discomfort
  • symptoms at rest
75
Q

what vastly improves outcomes for HF

A

med management

76
Q

nutrition wise for HF what do we do for sodium

A

restrict

<2-3 g /day
1.5 g/day - severe HR

77
Q

nutrition wise for HF what do we do for fluid restriction

A

1.5-2 L/day
- daily wts
- 1-1.5 kg (2-3lb) per day or 2.5 kg (5lbs) over 5-7 days

78
Q

what are 3 things to note about pharma for HF

A
  1. start low, go slow
  2. one med at a time
  3. re-evaluate symptoms, status, v/s, adverse events, lab values

sinus rhythm is the goal. if not 2nd goal is HR less than 70.

79
Q

all efforts treating HF pts should be 2 fold… what are the 2 things

A
  1. reduce HR to < 70 BPM
  2. restore NSR if not already
80
Q

how do we know what agent to start first for HF meds

A
  • usually afterload reduction (ACE/ARB( first, however this is not always a rule - it is a clinical decision.
    (are they hypotensive, tachycardiac, volume overloaded??)
  • meds are often held, interrupted, discontinued for inappropriate reasons.
81
Q

what’s common pharma for afib

A

beta blocker, CCB

82
Q

pharma management of MI

A

beta blocker, nitrates

83
Q

when are diuretics used

A

fluid overload

84
Q

meds for HF preserved Ejection Fraction

A
  • treatment targets associated conditions (HTN and edema)
  • AFib common - bb or CCB
  • MI - BB, nitrates
  • diuretics - volume overload
85
Q

HF reduced ejection fraction pharma management

A
  • ACE-I/ARB
  • B-Blocker
  • MRA
86
Q

describe ACE-I/ARB

A
  • inhibit the RAAS sys
  • block conversion of ATI to ATII lowering arteriolar resistance
  • also prevents release of aldosterone (opposes natriuresis)
  • afterload reduction
87
Q

describe b-blocker

A
  • competitive antagonists that block receptors of catecholamines of SNS
  • some are cardioselective (B1)
  • reduce HR, sllow for prolonged diastolic filling time
88
Q

describe MRA

A
  • mineralocorticoid receptor antagonist (receptor for aldosterone)
  • regulates Na reabsorption and fluid balance
89
Q

describe the new drug neprilysin inhibitor + example

A

ex: sacubitril
- decrease BP, sympathetic tone
- decrease aldosterone levels
- decrease myocardial fibrosis and hypertrophy
- increases natriuresis and diuresis

breaks down BMP ( so we don’t like this)

90
Q

describe the new drug angiotensin receptor neprilysin inhibitor + examples

A

ex: sacubitril/valsartan - entresto
- decreased Na and H2O retention
- decreased vasoconstriction, increased vasodilation
- decreased hypertrophy
- decreased fibrosis
- increases natriuresis and diuresis
- increased aldosterone suppression

91
Q

describe the new drug ivabradine-lancora + examples

A
  • acts on the l(subscript)f channel which is highly expressed in the sinoatrial node
  • reduces pacemaker rate selectively and allows more time for relaxation/end diastole
  • there is reduced HR w/o loss of contractility
  • NO BP lowering effects
  • therapy is added in addition to routine therapy (beta-blockers)
92
Q

describe the new drug glucose cotransporter 2 (SGLT2) inhibitor - dapalgliflozin + examples

A
  • may be used in persistently symptomatic pts who are alr optimized on other therapies
  • reduces reabsorption of filtered glucose from the tubular lumen and lowers the renal threshold for glucose (RT subscript G) result in increased urinary excretion of glucose, thereby reducing plasma glucose concentrations
  • reduces sodium reabsorption and increased sodium delivery to the distal tubule, which may decrease cardiac preload/afterload
  • improves myocardial metabolism and thus improve cardiac efficiency
  • may also have vascular effects (including improving endothelial function) that promote vasodilation and thus may also reduce afterload
93
Q

describe diuretics
1. thiazide
2. loop

A
  1. thiazide diuretics
    - inhibits Na reabsorption in distal tubule
  2. loop diuretics - promotes Na, Cl and H2O excretion in ascending loop of Henle
    - consider onset and duration of action
    - set targets - wt loss, FiO2 concentration, symptom resolution
    - is pt already taking lasix?
    - pt should be on PO lasix w stable symptoms/wt for 24 hrs prior to leaving the hospital
94
Q

describe vasodilators
1. nitroglycerin
2. renal impairment

A
  1. vasodilation, reduction of preload and afterload
  2. consider hydralazine and nitrates
95
Q

describe digoxin

A
  • acts by inhibiting the Na-K-ATPase pump
  • decreases HR (assess HR prior to administration)
  • increased myocyte contractile performance (increased shortening velocity) and improved overall LV systolic function
96
Q

how do we manage venous thromboembolism prophylaxis

A
  • anticoagulation
  • low dose unfractionated heparin or LMWH (for pts who are not alr anticoagulated and have no contraindications to anticoagulation)
  • not used for all pt’s w HF
  • HX of afib
  • EF <35%
97
Q

surgical interventions for HF

A
  • heart transplant
  • valvular replacement
  • coronary revascularization procedures (CABG, PCI)
98
Q

how long do HF pts usually have a change in symptoms b4 ER visit

99
Q

for HF exacerbations how do we recognize a change

A
  • increase in wt >2-3 lbs above baseline overnight or 5 lbs in a week
  • increase in orthopnea, PND
  • worsening dyspnea, edema
100
Q

can pts recover from HF

A

nah its progressive